Table 2.
Subjects | Anti-β2GPI alone (IgG or IgM) | Anti-PT alone (IgG) | Both anti-β2GPI and anti-PT | Neither | ||||
---|---|---|---|---|---|---|---|---|
Group B | 3/12 | 59·3% | 2/12 | 62·5% | 1/12 | 20% | 6/12 | 77·3% |
Group C | 5/13 | 22% | 2/13 | 28·5% | 4/13 | 21·7% | 2/13 | 42·5% |
Group D | 1/5 | 45% | 3/5 | 53% | Nil | 1/5 | 42% |
The presence of anti-β2-glycoprotein I (anti-β2GPI) and antiprothrombin (anti-PT) antibodies has been shown for each of the three aPL patient groups.